Bruce Neal's Publications

• Canagliflozin and Risk of Genital Infections and Urinary Tract Infections in People with Diabetes Mellitus and Kidney Disease in the CREDENCE Trial

  Journal articles

  2020

  Journal of the American Society of Nephrology

• Canagliflozin and Risk of Skin and Soft Tissue Infections in People with Diabetes Mellitus and Kidney Disease in the CREDENCE Trial

  Journal articles

  2020

  Journal of the American Society of Nephrology

• Effects of Canagliflozin on Major Adverse Cardiovascular Events in Patients with Different Baseline Levels of Type 2 Diabetes Disease Severity: Results from the CANVAS Program

  Journal articles

  2020

  Journal of the American Society of Nephrology

• Canagliflozin Across the Spectrum of Kidney Function and Albuminuria: Integrated Data from CANVAS and CREDENCE

  Journal articles

  2020

  Journal of the American Society of Nephrology

• Effects of Canagliflozin on Cardiovascular, Renal, and Safety Outcomes by Baseline Loop Diuretic Use: Data from the CREDENCE Trial

  Journal articles

  2020

  Journal of the American Society of Nephrology

• THE EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE AND CARDIOVASCULAR DEATH BY BASELINE PARTICIPANT CHARACTERISTICS: ANALYSIS OF THE CREDENCE TRIAL

  Journal articles

  2020

  Journal of the American College of Cardiology

• Measuring the healthiness of child-targeted cereals: a study of the FoodSwitch platform in Sweden

  Journal articles

  2020

  Journal of Medical Internet Research

• Contribution of major food companies and their products to household dietary sodium purchases in Australia

  Preprints

  2019

• Front-of-pack nutrition labelling to promote healthier diets: Current practice and opportunities to strengthen regulation worldwide

  Journal articles

  2019

  BMJ Global Health

• The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program

  Journal articles

  2019

  The Lancet Rheumatology

• Canagliflozin Reduces Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Chronic Kidney Disease Regardless of Baseline HbA1c, Including Those With HbA1c 7%: Results From the CREDENCE Trial

  Conference Papers

  2019

  CIRCULATION

• Do GLP-1 receptor agonists care if you have heart failure?

  Journal articles

  2019

  Circulation

• SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

  Journal articles

  2019

  The Lancet Diabetes and Endocrinology

• Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: The Survey of PatIents with treatment ResIstant hyperTension study

  Journal articles

  2019

  Journal of Hypertension

• A comparison of the healthiness of packaged foods and beverages from 12 countries using the Health Star Rating nutrient profiling system, 20132018

  Journal articles

  2019

  Obesity Reviews

• Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

  Journal articles

  2019

  Diabetologia

• An exploration of factors mediating the effects of canagliflozin on heart failure in patients with type 2 diabetes

  Conference Abstracts

  2019

  DIABETOLOGIA

• Canagliflozin in patients with type 2 diabetes and macroalbuminuria: data from the CANVAS program

  Conference Abstracts

  2019

  DIABETOLOGIA

• The effects of canagliflozin on uric acid and gout in patients with type 2 diabetes in the CANVAS programme

  Conference Abstracts

  2019

  DIABETOLOGIA

• Impact of dose and duration of dietary salt reduction on blood pressure levels: systematic review and meta-analysis of randomised trials

  Conference Papers

  2019

  EUROPEAN HEART JOURNAL

• Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups: Results from the Randomized CREDENCE Trial

  Journal articles

  2019

  Circulation

• Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial

  Journal articles

  2019

  Journal of Renal Nutrition

• Erratum: Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 19902017: a systematic analysis for the Global Burden of Disease Study 2017 (The Lancet (2018) 392(10159) (19231994), (S0140673618322256), (10.1016S0140-6736(18)32225-6))

  Journal articles

  2019

  The Lancet

• DIFFERENT EGFR THRESHOLDS AND THE RENAL EFFECTS OF CANAGLIFLOZIN: DATA FROM THE CANVAS PROGRAM

  Conference Abstracts

  2019

  NEPHROLOGY DIALYSIS TRANSPLANTATION